Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Fulgent Genetics, Inc. (FLGT) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Fulgent Genetics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1674930.
Total stock buying since 2016: $11,155,087.
Total stock sales since 2016: $32,816,355.
Total stock option exercises since 2016: $86,631.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 100,000 | $1,596,500 | 10,378 | $219,186 | 0 | $0 |
2024 | 0 | $0 | 15,336 | $320,962 | 0 | $0 |
2023 | 0 | $0 | 43,816 | $1,292,779 | 0 | $0 |
2022 | 0 | $0 | 21,389 | $1,156,739 | 2,501 | $19,017 |
2021 | 0 | $0 | 121,980 | $11,373,932 | 4,060 | $23,176 |
2020 | 0 | $0 | 341,634 | $14,957,817 | 10,393 | $44,438 |
2019 | 8,739 | $43,240 | 39,736 | $437,980 | 0 | $0 |
2018 | 20,880 | $72,647 | 5,849 | $22,601 | 0 | $0 |
2017 | 106,763 | $442,700 | 7,707 | $40,084 | 0 | $0 |
2016 | 1,000,000 | $9,000,000 | 2,565,789 | $2,994,275 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2025-09 | 0 | $0 | 2,191 | $48,260 | 0 | $0 |
2025-08 | 0 | $0 | 3,386 | $72,768 | 0 | $0 |
2025-06 | 0 | $0 | 1,889 | $38,329 | 0 | $0 |
2025-05 | 0 | $0 | 2,912 | $59,829 | 0 | $0 |
2025-03 | 100,000 | $1,596,500 | 0 | $0 | 0 | $0 |
2024-12 | 0 | $0 | 2,828 | $55,145 | 0 | $0 |
2024-11 | 0 | $0 | 3,413 | $62,316 | 0 | $0 |
2024-09 | 0 | $0 | 4,771 | $104,774 | 0 | $0 |
2024-08 | 0 | $0 | 4,324 | $98,727 | 0 | $0 |
2023-12 | 0 | $0 | 26,653 | $711,384 | 0 | $0 |
2023-11 | 0 | $0 | 2,924 | $79,681 | 0 | $0 |
2023-09 | 0 | $0 | 4,025 | $126,415 | 0 | $0 |
2023-08 | 0 | $0 | 3,447 | $116,787 | 0 | $0 |
2023-06 | 0 | $0 | 3,836 | $154,575 | 0 | $0 |
2023-05 | 0 | $0 | 2,931 | $103,937 | 0 | $0 |
2022-11 | 0 | $0 | 3,444 | $123,607 | 0 | $0 |
2022-06 | 0 | $0 | 415 | $22,867 | 0 | $0 |
2022-05 | 0 | $0 | 14,579 | $830,277 | 626 | $3,046 |
2022-03 | 0 | $0 | 2,951 | $179,988 | 1,875 | $15,971 |
2021-12 | 0 | $0 | 620 | $51,557 | 0 | $0 |
2021-11 | 0 | $0 | 14,593 | $1,393,978 | 0 | $0 |
2021-09 | 0 | $0 | 607 | $57,235 | 0 | $0 |
2021-08 | 0 | $0 | 4,777 | $448,407 | 936 | $7,972 |
2021-06 | 0 | $0 | 1,250 | $91,472 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-09-03 | Xie Jian (President and COO) | Sale | 1,128 | 22.03 | 24,846 |
2025-09-03 | Gao Hanlin (Chief Scientific Officer) | Sale | 1,063 | 22.03 | 23,414 |
2025-08-27 | Xie Jian (President and COO) | Sale | 1,199 | 21.48 | 25,760 |
2025-08-27 | Gao Hanlin (Chief Scientific Officer) | Sale | 943 | 21.48 | 20,260 |
2025-08-25 | Xie Jian (President and COO) | Sale | 696 | 21.50 | 14,965 |
2025-08-25 | Gao Hanlin (Chief Scientific Officer) | Sale | 548 | 21.50 | 11,783 |
2025-06-02 | Xie Jian (President and COO) | Sale | 1,135 | 20.29 | 23,030 |
2025-06-02 | Gao Hanlin (Chief Scientific Officer) | Sale | 754 | 20.29 | 15,299 |
2025-05-27 | Xie Jian (President and COO) | Sale | 1,873 | 20.55 | 38,482 |
2025-05-27 | Gao Hanlin (Chief Scientific Officer) | Sale | 1,039 | 20.55 | 21,347 |
2025-03-05 | Kim Paul (CFO and Treasurer) | Buy | 100,000 | 15.96 | 1,596,500 |
2024-12-03 | Xie Jian (President and COO) | Sale | 1,455 | 19.50 | 28,372 |
2024-12-03 | Gao Hanlin (Chief Scientific Officer) | Sale | 1,373 | 19.50 | 26,773 |
2024-11-25 | Xie Jian (President and COO) | Sale | 689 | 18.26 | 12,580 |
2024-11-25 | Gao Hanlin (Chief Scientific Officer) | Sale | 497 | 18.26 | 9,074 |
2024-11-25 | Hsieh Ming (Chief Executive Officer) | Sale | 2,227 | 18.26 | 40,662 |
2024-09-03 | Xie Jian (President and COO) | Sale | 1,594 | 21.96 | 35,005 |
2024-09-03 | Gao Hanlin (Chief Scientific Officer) | Sale | 1,503 | 21.96 | 33,007 |
2024-09-03 | Kim Paul (CFO and Treasurer) | Sale | 1,674 | 21.96 | 36,762 |
2024-08-27 | Xie Jian (President and COO) | Sale | 715 | 22.83 | 16,325 |
2024-08-27 | Gao Hanlin (Chief Scientific Officer) | Sale | 563 | 22.83 | 12,854 |
2024-08-27 | Hsieh Ming (Chief Executive Officer) | Sale | 2,313 | 22.83 | 52,812 |
2024-08-27 | Kim Paul (CFO and Treasurer) | Sale | 733 | 22.83 | 16,736 |
2023-12-11 | Xie Jian (President and COO) | Sale | 22,000 | 26.50 | 583,088 |
2023-12-04 | Xie Jian (President and COO) | Sale | 1,779 | 27.57 | 49,052 |
2023-12-04 | Gao Hanlin (Chief Scientific Officer) | Sale | 1,437 | 27.57 | 39,622 |
2023-12-04 | Kim Paul (CFO and Treasurer) | Sale | 1,437 | 27.57 | 39,622 |
2023-11-16 | Xie Jian (President and COO) | Sale | 1,617 | 27.25 | 44,064 |
2023-11-16 | Kim Paul (CFO and Treasurer) | Sale | 1,307 | 27.25 | 35,617 |
2023-09-07 | Xie Jian (President and COO) | Sale | 1,492 | 31.41 | 46,860 |
2023-09-07 | Gao Hanlin (Chief Scientific Officer) | Sale | 1,041 | 31.41 | 32,695 |
2023-09-07 | Kim Paul (CFO and Treasurer) | Sale | 1,492 | 31.41 | 46,860 |
2023-08-17 | Xie Jian (President and COO) | Sale | 1,307 | 33.88 | 44,282 |
2023-08-17 | Gao Hanlin (Chief Scientific Officer) | Sale | 342 | 33.88 | 11,587 |
2023-08-17 | Kim Paul (CFO and Treasurer) | Sale | 1,798 | 33.88 | 60,918 |
2023-06-02 | Xie Jian (President and COO) | Sale | 1,433 | 40.30 | 57,744 |
2023-06-02 | Gao Hanlin (Chief Scientific Officer) | Sale | 1,000 | 40.30 | 40,296 |
2023-06-02 | Kim Paul (CFO and Treasurer) | Sale | 1,403 | 40.30 | 56,535 |
2023-05-17 | Xie Jian (President and COO) | Sale | 1,320 | 35.46 | 46,809 |
2023-05-17 | Gao Hanlin (Chief Scientific Officer) | Sale | 345 | 35.46 | 12,234 |
2023-05-17 | Kim Paul (CFO and Treasurer) | Sale | 1,266 | 35.46 | 44,894 |
2022-11-16 | Xie Jian (President and COO) | Sale | 1,306 | 35.89 | 46,873 |
2022-11-16 | Gao Hanlin (Chief Scientific Officer) | Sale | 342 | 35.89 | 12,274 |
2022-11-16 | Kim Paul (CFO and Treasurer) | Sale | 1,796 | 35.89 | 64,460 |
2022-06-02 | Kim Paul (CFO and Treasurer) | Sale | 415 | 55.10 | 22,867 |
2022-05-31 | Xie Jian (President and COO) | Sale | 668 | 54.54 | 36,433 |
2022-05-31 | Bolger John C (Director) | Sale | 1,126 | 55.34 | 62,307 |
2022-05-31 | Bolger John C (Director) | Option Ex | 626 | 4.87 | 3,046 |
2022-05-19 | Xie Jian (President and COO) | Sale | 10,000 | 58.29 | 582,870 |
2022-05-16 | Xie Jian (President and COO) | Sale | 1,269 | 53.38 | 67,741 |
2022-05-16 | Gao Hanlin (Chief Scientific Officer) | Sale | 325 | 53.38 | 17,349 |
2022-05-16 | Kim Paul (CFO and Treasurer) | Sale | 1,191 | 53.38 | 63,577 |
2022-03-03 | Kim Paul (CFO and Treasurer) | Sale | 454 | 56.31 | 25,563 |
2022-03-01 | Xie Jian (Chief Operating Officer) | Sale | 622 | 63.30 | 39,370 |
2022-03-01 | Bolger John C (Director) | Sale | 1,875 | 61.36 | 115,055 |
2022-03-01 | Bolger John C (Director) | Option Ex | 1,875 | 8.52 | 15,971 |
2021-12-02 | Kim Paul (CFO and Treasurer) | Sale | 620 | 83.16 | 51,557 |
2021-11-29 | Xie Jian (Chief Operating Officer) | Sale | 636 | 95.42 | 60,685 |
2021-11-19 | Kim Paul (CFO and Treasurer) | Sale | 10,263 | 95.44 | 979,531 |
2021-11-18 | Kim Paul (CFO and Treasurer) | Sale | 500 | 97.46 | 48,730 |
2021-11-16 | Xie Jian (Chief Operating Officer) | Sale | 1,214 | 95.50 | 115,939 |
2021-11-16 | Gao Hanlin (Chief Scientific Officer) | Sale | 311 | 95.50 | 29,701 |
2021-11-16 | Kim Paul (CFO and Treasurer) | Sale | 1,669 | 95.50 | 159,392 |
2021-09-02 | Kim Paul (CFO and Treasurer) | Sale | 607 | 94.29 | 57,235 |
2021-08-30 | Xie Jian (Chief Operating Officer) | Sale | 622 | 91.25 | 56,759 |
2021-08-30 | Bolger John C (Director) | Sale | 936 | 91.29 | 85,449 |
2021-08-30 | Bolger John C (Director) | Option Ex | 936 | 8.52 | 7,972 |
2021-08-16 | Xie Jian (Chief Operating Officer) | Sale | 1,223 | 95.12 | 116,335 |
2021-08-16 | Gao Hanlin (Chief Scientific Officer) | Sale | 314 | 95.12 | 29,868 |
2021-08-16 | Kim Paul (CFO and Treasurer) | Sale | 1,682 | 95.12 | 159,996 |
2021-06-04 | Kim Paul (CFO and Treasurer) | Sale | 789 | 74.26 | 58,587 |
2021-06-02 | Kim Paul (CFO and Treasurer) | Sale | 461 | 71.34 | 32,885 |
2021-05-26 | Kim Paul (CFO and Treasurer) | Sale | 18,000 | 72.90 | 1,312,128 |
2021-05-25 | Kim Paul (CFO and Treasurer) | Sale | 10,358 | 72.94 | 755,481 |
2021-05-20 | Xie Jian (Chief Operating Officer) | Sale | 1,000 | 74.48 | 74,480 |
2021-05-18 | Xie Jian (Chief Operating Officer) | Sale | 931 | 70.71 | 65,831 |
2021-05-18 | Gao Hanlin (Chief Scientific Officer) | Sale | 315 | 70.71 | 22,273 |
2021-05-18 | Kim Paul (CFO and Treasurer) | Sale | 1,155 | 70.71 | 81,670 |
2021-03-15 | Xie Jian (Chief Operating Officer) | Sale | 3,000 | 104.10 | 312,300 |
2021-03-09 | Xie Jian (Chief Operating Officer) | Sale | 62,000 | 102.65 | 6,364,238 |
2021-03-09 | Bolger John C (Director) | Sale | 3,374 | 101.62 | 342,882 |
2021-03-09 | Bolger John C (Director) | Option Ex | 3,124 | 4.87 | 15,204 |
2020-12-10 | Kim Paul (CFO and Treasurer) | Sale | 16,958 | 51.94 | 880,730 |
2020-12-09 | Kim Paul (CFO and Treasurer) | Sale | 10,662 | 51.60 | 550,191 |
2020-12-02 | Xie Jian (Chief Operating Officer) | Sale | 1,000 | 46.00 | 46,000 |
2020-12-02 | Kim Paul (CFO and Treasurer) | Sale | 29,949 | 45.85 | 1,373,191 |
2020-12-01 | Xie Jian (Chief Operating Officer) | Sale | 1,000 | 45.16 | 45,160 |
2020-11-30 | Xie Jian (Chief Operating Officer) | Sale | 3,396 | 43.38 | 147,311 |
2020-11-23 | Xie Jian (Chief Operating Officer) | Sale | 6,000 | 44.08 | 264,480 |
2020-11-20 | Xie Jian (Chief Operating Officer) | Sale | 1,000 | 42.50 | 42,500 |
2020-11-18 | Xie Jian (Chief Operating Officer) | Sale | 3,000 | 44.83 | 134,499 |
2020-11-17 | Xie Jian (Chief Operating Officer) | Sale | 3,706 | 45.03 | 166,870 |
2020-11-17 | Gao Hanlin (Chief Scientific Officer) | Sale | 301 | 45.45 | 13,680 |
2020-11-17 | Kim Paul (CFO and Treasurer) | Sale | 3,767 | 45.45 | 171,206 |
2020-11-17 | Bolger John C (Director) | Sale | 4,269 | 44.24 | 188,877 |
2020-11-17 | Bolger John C (Director) | Option Ex | 2,631 | .38 | 999 |
2020-11-16 | Kim Paul (CFO and Treasurer) | Sale | 100,000 | 46.17 | 4,617,000 |
2020-09-02 | Kim Paul (CFO and Treasurer) | Sale | 425 | 28.32 | 12,034 |
2020-08-28 | Xie Jian (Chief Operating Officer) | Sale | 441 | 30.82 | 13,591 |
2020-08-19 | Kim Paul (CFO and Treasurer) | Sale | 25,407 | 44.16 | 1,122,049 |
2020-08-17 | Gao Hanlin (Chief Scientific Officer) | Sale | 1,308 | 41.11 | 53,771 |
2020-08-17 | Kim Paul (CFO and Treasurer) | Sale | 111,236 | 42.04 | 4,676,806 |
2020-08-17 | Bolger John C (Director) | Sale | 3,914 | 40.87 | 159,969 |
2020-08-17 | Bolger John C (Director) | Option Ex | 2,631 | 12.31 | 32,392 |
2020-08-11 | Kim Paul (CFO and Treasurer) | Sale | 1,396 | 42.06 | 58,711 |
2020-08-03 | Xie Jian (Chief Operating Officer) | Sale | 1,976 | 27.86 | 55,055 |
2020-06-02 | Kim Paul (CFO and Treasurer) | Sale | 425 | 18.06 | 7,673 |
2020-05-22 | Bolger John C (Director) | Sale | 8,677 | 15.36 | 133,287 |
2020-05-22 | Bolger John C (Director) | Option Ex | 5,131 | 2.15 | 11,047 |
2020-05-12 | Kim Paul (CFO and Treasurer) | Sale | 1,421 | 16.31 | 23,176 |
2019-08-12 | Kim Paul (CFO and Treasurer) | Sale | 24,778 | 11.43 | 283,212 |
2019-05-13 | Kim Paul (CFO and Treasurer) | Sale | 1,404 | 5.50 | 7,722 |
2019-03-05 | Hsieh Ming (President and CEO) | Buy | 8,739 | 4.95 | 43,240 |
2019-03-05 | Kim Paul (CFO and Treasurer) | Sale | 1,165 | 4.67 | 5,440 |
2018-11-13 | Hsieh Ming (President and CEO) | Buy | 10,880 | 3.59 | 39,037 |
2018-11-13 | Kim Paul (CFO and Treasurer) | Sale | 1,446 | 3.50 | 5,062 |
2018-11-09 | Hsieh Ming (President and CEO) | Buy | 10,000 | 3.36 | 33,610 |
2018-08-13 | Kim Paul (CFO and Treasurer) | Sale | 1,405 | 4.50 | 6,322 |
2018-05-14 | Kim Paul (CFO and Treasurer) | Sale | 1,370 | 3.72 | 5,096 |
2018-03-08 | Kim Paul (CFO and Treasurer) | Sale | 1,628 | 3.76 | 6,121 |
2017-11-30 | Hsieh Ming (President and CEO) | Buy | 2,000 | 3.60 | 7,208 |
2017-11-21 | Hsieh Ming (President and CEO) | Buy | 1,599 | 3.12 | 4,996 |
2017-11-20 | Hsieh Ming (President and CEO) | Buy | 7,259 | 3.28 | 23,809 |
2017-11-17 | Hsieh Ming (President and CEO) | Buy | 12,291 | 3.16 | 38,864 |
2017-11-16 | Hsieh Ming (President and CEO) | Buy | 1,905 | 3.22 | 6,136 |
2017-11-15 | Hsieh Ming (President and CEO) | Buy | 300 | 3.28 | 984 |
2017-11-14 | Hsieh Ming (President and CEO) | Buy | 2,800 | 3.35 | 9,374 |
2017-11-13 | Hsieh Ming (President and CEO) | Buy | 7,704 | 3.28 | 25,269 |
2017-11-13 | Kim Paul (CFO and Treasurer) | Sale | 1,573 | 3.22 | 5,065 |
2017-11-10 | Hsieh Ming (President and CEO) | Buy | 9,385 | 3.35 | 31,402 |
2017-11-09 | Hsieh Ming (President and CEO) | Buy | 11,520 | 3.48 | 40,032 |
2017-08-11 | Kim Paul (CFO and Treasurer) | Sale | 6,134 | 5.71 | 35,019 |
2017-06-15 | Hsieh Ming (President and CEO) | Buy | 12,700 | 5.35 | 67,945 |
2017-06-14 | Hsieh Ming (President and CEO) | Buy | 7,300 | 5.11 | 37,281 |
2017-06-13 | Hsieh Ming (President and CEO) | Buy | 15,000 | 5.01 | 75,195 |
2017-06-12 | Hsieh Ming (President and CEO) | Buy | 15,000 | 4.95 | 74,205 |
2016-09-30 | Hsieh Ming (President and CEO) | Buy | 1,000,000 | 9.00 | 9,000,000 |
2016-05-13 | Gao Hanlin (Chief Scientific Officer) | Sale | 2,565,789 | 1.17 | 2,994,275 |
Insider trading activities including stock purchases, stock sales, and option exercises of FLGT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Fulgent Genetics, Inc. (symbol FLGT, CIK number 1674930) see the Securities and Exchange Commission (SEC) website.